AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $2.302M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 10.00am 03/08/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 0.0¢ | Day High | 0.0¢ | Day Low | 0.0¢ | |||
| Daily Volume | 0 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 0.5¢ | 0 | 0 | 0.5¢ | 0 | |
Directors & Senior Management
| Prof. Adam Osseiran | Member of Advisory Board |
| Mr. Andrew Chapman | Non-Executive Chairman |
| Mr. Ariel Edward King | Director |
| Mr. Craig Smith-Gander | Chief Cycling Officer |
| Mr. David Colin Wheeler | Independent Non-Executive Director |
| Mr. Rhys Campbell | Chief Technology Officer |
| Mr. Timothy Ryan Slate | CFO & Company Secretary |
Data source: ADVFN
